Doxapram and developmental delay at 12 months in children born extremely preterm

Ane Lando, Anja Klamer, Finn Jonsbo, Janne Weiss, Gorm Greisen

11 Citationer (Scopus)

Abstract

AIM: To examine the relation of doxapram to a developmental score achieved by a structured telephone interview in a group of extremely-preterm-born children.

METHODS: Parents of 88 children born extremely preterm were contacted by telephone and interviewed by a structured questionnaire (R-PDQ) when the corrected age of their child was 9-15 mo.

RESULTS: We found that doxapram treatment was associated with a deficit in age-adjusted R-PDQ score.

CONCLUSION: Doxapram may have a negative effect on neurodevelopmental outcome.

OriginalsprogEngelsk
TidsskriftActa paediatrica
Vol/bind94
Udgave nummer11
Sider (fra-til)1680-1
Antal sider2
ISSN0803-5253
DOI
StatusUdgivet - nov. 2005

Fingeraftryk

Dyk ned i forskningsemnerne om 'Doxapram and developmental delay at 12 months in children born extremely preterm'. Sammen danner de et unikt fingeraftryk.

Citationsformater